We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

OraSure Technologies Inc (OSUR) Com Stk Npv

Sell:$8.97 Buy:$8.98 Change: $0.03 (0.34%)
Market closed |  Prices as at close on 7 December 2021 | Switch to live prices |
Change: $0.03 (0.34%)
Market closed |  Prices as at close on 7 December 2021 | Switch to live prices |
Change: $0.03 (0.34%)
Market closed |  Prices as at close on 7 December 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

OraSure Technologies, Inc. (OraSure) is a medical device company that develops, manufactures, and markets medical devices and diagnostic products. The Company's products include molecular sampling kits for the genome and microbiome services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse. OraSure’s segments include Diagnostics segment and Molecular Collection Systems segment. The Diagnostics business primarily consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. The Molecular Solutions business consists of the manufacture and sale of kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbiome and animal genetics markets.

Contact details

United States
+1 (503) 6416115

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$626.73 million
Shares in issue:
72.04 million
Health Care Supplies
United States
US dollar

Key personnel

  • Stephen Tang
    President, Chief Executive Officer, Director
  • Scott Gleason
    Interim Chief Financial Officer, Senior Vice President of Investor Relations and Corporate Communications
  • Lisa Nibauer
    Executive Vice President, Business Unit Leader, Diagnostics
  • Kathleen Weber
    Executive Vice President, Business Unit Leader, Molecular Solutions at DNAG
  • Jack Jerrett
    Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
  • Agnieszka Gallagher
    Chief Compliance Officer, General Counsel, Secretary
  • Michele Miller
    Vice President - Finance, Controller, Assistant Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.